Restrictive Coverage Policies and Patient Access

Please read this timely article by Mark Ballow, M.D. published in Healthcare Payer News. Dr. Ballow addresses restrictive coverage policies that have a negative impact on patient access and patient care; particularly focusing on patients with primary immunodeficiency diseases.

PPTA News

Karen Etchberger Elected Chair of PPTA Global Board of Directors +

Annapolis, MD (January 13, 2020) —The Global Board of Directors of the Plasma Protein Therapeutics Association(PPTA) elected Karen Etchberger of CSL Behring as its Chair, effective January 2020. Dr. Etchberger will serve a three-year term and succeeds outgoing Chair, David Bell, Grifols S.A.
Read More
Fabrizio Fabbrizzi – 10 April 1955 - 2 January 2020 +

The new year has started badly. Fabrizio Fabbrizzi, one of the most respected and beloved stalwarts of the plasma products landscape, passed on 2 January 2020 after a brief struggle with a serious illness. Fabrizio was born in Barga, Tuscany on 10 April 1955 and graduated in medicine and surgery at the University of Pisa in 1981.
Read More
PPTA Statement on H.R. 3 +

On December 12, the U.S. House of Representatives passed H.R. 3, “The Lower Drug Costs Act,” sponsored by Energy & Commerce Chairman, Rep. Frank Pallone, D- NJ. This bill, known as Speaker Pelosi’s drug plan, would put at risk patients with rare diseases who rely on access to plasma protein therapies.
Read More